|
English
|
正體中文
|
简体中文
|
2818750
|
|
???header.visitor??? :
28343034
???header.onlineuser??? :
451
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"perng r"???jsp.browse.items-by-author.description???
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國家衛生研究院 |
2009-05-20 |
Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged >= 70 years in Taiwan
|
Chen, Y;Tsai, C;Shih, J;Perng, R;Whang-Peng, J |
| 國家衛生研究院 |
2003-04 |
Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy
|
Chen, Y;Lee, C;Lin, W;Tsai, C;Perng, R |
| 國家衛生研究院 |
1999-12 |
Depressed cytolytic activity of peripheral blood mononuclear cells in unusually high paclitaxel concentrations: Reversal by IL-2 and IL-12
|
Chen, Y;Yang, W;Ting, C;Yang, D;Whang-Peng, J;Perng, R |
| 國家衛生研究院 |
1998-07 |
Ifosfamide-based chemotherapy for previously treated lung cancer patients
|
Chen, Y;Liu, J;Wu, M;Wu, H;Lin, W;Tsai, C;Perng, R;Whang-Peng, J |
| 國家衛生研究院 |
1997 |
Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer
|
Wu, M;Perng, R;Chen, Y;Liu, J;Yang, S;Whang-Peng, J |
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
